Jung‐Hwan Yoon

20.5k total citations · 3 hit papers
425 papers, 13.6k citations indexed

About

Jung‐Hwan Yoon is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Jung‐Hwan Yoon has authored 425 papers receiving a total of 13.6k indexed citations (citations by other indexed papers that have themselves been cited), including 265 papers in Hepatology, 248 papers in Epidemiology and 77 papers in Surgery. Recurrent topics in Jung‐Hwan Yoon's work include Liver Disease Diagnosis and Treatment (195 papers), Hepatocellular Carcinoma Treatment and Prognosis (134 papers) and Hepatitis B Virus Studies (114 papers). Jung‐Hwan Yoon is often cited by papers focused on Liver Disease Diagnosis and Treatment (195 papers), Hepatocellular Carcinoma Treatment and Prognosis (134 papers) and Hepatitis B Virus Studies (114 papers). Jung‐Hwan Yoon collaborates with scholars based in South Korea, Ethiopia and United States. Jung‐Hwan Yoon's co-authors include Yoon Jun Kim, Jeong‐Hoon Lee, Su Jong Yu, Won Kim, Hyo-Suk Lee, Gregory J. Gores, Eun Ju Cho, Donghee Kim, Goh Eun Chung and Chung Yong Kim and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Jung‐Hwan Yoon

405 papers receiving 13.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease

2009 1.1k citations Jeong‐Hoon Lee, Won Kim et al. profile →
Liver homeostasis is maintained by midlobular zone 2 hepatocytes

2021 163 citations Jung‐Hwan Yoon et al. profile →
EMERALD-1: A phase 3, randomized, placebo-controlled study of transarterial chemoembolization combined with durvalumab with or without bevacizumab in participants with unresectable hepatocellular carcinoma eligible for embolization.

2024 93 citations Jeong Heo, Jung‐Hwan Yoon et al. profile →

Peers

Countries citing papers authored by Jung‐Hwan Yoon

Since Specialization

Citations

This map shows the geographic impact of Jung‐Hwan Yoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung‐Hwan Yoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung‐Hwan Yoon more than expected).

Fields of papers citing papers by Jung‐Hwan Yoon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jung‐Hwan Yoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung‐Hwan Yoon. The network helps show where Jung‐Hwan Yoon may publish in the future.

Co-authorship network of co-authors of Jung‐Hwan Yoon

This figure shows the co-authorship network connecting the top 25 collaborators of Jung‐Hwan Yoon. A scholar is included among the top collaborators of Jung‐Hwan Yoon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jung‐Hwan Yoon. Jung‐Hwan Yoon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Predictive Value of Time‐Varying Noninvasive Scores on Long‐Term Prognosis of NAFLD in South Korea 2024 ·Canadian Journal of Gastroenterology and Hepatology ·Sung Won Chung, Min Kyung Park, Xiao Zhang, Tongtong Wang, Thomas Jemielita, Gail Fernandes, Samuel S. Engel, Heejoon Jang, Yun Bin Lee, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Jung‐Hwan Yoon, Yoon Jun Kim	0
2	No-Touch Radiofrequency Ablation Using Twin Cooled Wet Electrodes for Recurrent Hepatocellular Carcinoma Following Locoregional Treatments 2024 ·Korean Journal of Radiology ·(unknown), Jae Hyun Kim, Jeong Hee Yoon, Junghoan Park, Jung‐Hwan Yoon, Yoon Jun Kim, Su Jong Yu, Eun Ju Cho, Jeong Min Lee	1
3	FRI-397 A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B 2024 ·Journal of Hepatology ·(unknown), Seung Up Kim, Hyun Woong Lee, Han Ah Lee, Hyung‐Chul Lee, Sang Hoon Ahn, Beom Kyung Kim, Hwi Young Kim, Yeon Seok Seo, (unknown), (unknown), (unknown), (unknown), Yun Bin Lee, Su Jong Yu, Yoon Jun Kim, Jung‐Hwan Yoon, Jeong‐Hoon Lee	0
4	Association between the fatty liver index and the risk of fracture among individuals over the age of 50 years: a nationwide population-based study 2023 ·Frontiers in Endocrinology ·Goh Eun Chung, Eun Ju Cho, Min Joo Kim, Jeong‐Ju Yoo, Yuri Cho, (unknown), Kyungdo Han, Yoon Jun Kim, Jung‐Hwan Yoon, Dong Wook Shin, Su Jong Yu	3
5	Effects of Additives on Greenhouse Gas Emission during Organic Waste Composting 2023 ·Korean Journal of Environmental Agriculture ·(unknown), Byung‐Jun Park, Jung‐Hwan Yoon, (unknown), Jae E. Yang, (unknown)	0
6	Differential risk of 23 site‐specific incident cancers and cancer‐related mortality among patients with metabolic dysfunction‐associated fatty liver disease: a population‐based cohort study with 9.7 million Korean subjects 2023 ·Cancer Communications ·Goh Eun Chung, Su Jong Yu, Jeong‐Ju Yoo, Yuri Cho, (unknown), Dong Wook Shin, Yoon Jun Kim, Jung‐Hwan Yoon, Kyungdo Han, Eun Ju Cho	13
7	Gamma-glutamyl transferase and risk of all-cause and disease-specific mortality: a nationwide cohort study 2023 ·Scientific Reports ·Eun Ju Cho, Su‐Min Jeong, Goh Eun Chung, Jeong‐Ju Yoo, Yuri Cho, (unknown), Dong Wook Shin, Yoon Jun Kim, Jung‐Hwan Yoon, Kyungdo Han, Su Jong Yu	20
8	COVID-19 Vaccination Alters NK Cell Dynamics and Transiently Reduces HBsAg Titers Among Patients With Chronic Hepatitis B 2023 ·Immune Network ·(unknown), (unknown), Ji Yun Noh, June‐Young Koh, (unknown), (unknown), Sung Won Chung, (unknown), Min Kyung Park, Yun Bin Lee, Yoon Jun Kim, Jung‐Hwan Yoon, Jae‐Hoon Ko, Kyong Ran Peck, Joon Young Song, Eui‐Cheol Shin, Jeong‐Hoon Lee	1
9	Effectiveness of US Surveillance of Hepatocellular Carcinoma in Chronic Hepatitis B: US LI-RADS Visualization Score 2023 ·Radiology ·Min Kyung Park, Dong Ho Lee, Bo Yun Hur, Hyung‐Chul Lee, Yun Bin Lee, Su Jong Yu, Yoon Jun Kim, Jung‐Hwan Yoon, Jeong‐Hoon Lee	11
10	Yttrium-90 Radioembolization Is Associated with Better Clinical Outcomes in Patients with Hepatocellular Carcinoma Compared with Conventional Chemoembolization: A Propensity Score-Matched Study 2021 ·SHILAP Revista de lepidopterología ·(unknown), Heejoon Jang, (unknown), Joon Yeul Nam, Yun Bin Lee, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Hyo‐Cheol Kim, Jin Wook Chung, Jung‐Hwan Yoon, Yoon Jun Kim	11
11	Effectiveness of Transarterial Chemoembolization-First Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis 2021 ·Journal of Hepatocellular Carcinoma ·Sung Won Chung, Min Kyung Park, Young Youn Cho, (unknown), (unknown), Hyunwoo Oh, Heejoon Jang, (unknown), Sun Woong Kim, Joon Yeul Nam, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Hyo‐Cheol Kim, Yoon Jun Kim, Jin Wook Chung, Jung‐Hwan Yoon, Jeong‐Hoon Lee	2
12	Phase II Study of Avelumab in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib 2020 ·Clinical Cancer Research ·Dae-Won Lee, Eun Ju Cho, (unknown), Su Jong Yu, Yoon Jun Kim, Jung‐Hwan Yoon, Tae‐Yong Kim, Sae‐Won Han, Do‐Youn Oh, Seock‐Ah Im, Tae‐You Kim, Young-Eun Lee, Haeryoung Kim, Kyung-Hun Lee	33
13	Risk of Liver Cirrhosis and Hepatocellular Carcinoma after Fontan Operation: A Need for Surveillance 2020 ·Cancers ·Jun Sik Yoon, Dong Ho Lee, Eun Ju Cho, Mi Kyoung Song, Young Hun Choi, Gi Beom Kim, Yun Bin Lee, Jeong‐Hoon Lee, Su Jong Yu, Haeryoung Kim, Yoon Jun Kim, Jung‐Hwan Yoon, Eun Jung Bae	25
14	Circulating Microbiota-Based Metagenomic Signature for Detection of Hepatocellular Carcinoma 2019 ·Scientific Reports ·Eun Ju Cho, Sangseob Leem, Sunah Kim, Jinho Yang, Yun Bin Lee, Soon Sun Kim, Jae Youn Cheong, Sung Won Cho, Ji Won Kim, Sungmin Kim, Jung‐Hwan Yoon, Taesung Park	72
15	Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy 2017 ·Alimentary Pharmacology & Therapeutics ·Seong Hee Kang, Yun Bin Lee, Jeong‐Hoon Lee, Joon Yeul Nam, Young Woon Chang, Hyeki Cho, Jeong‐Ju Yoo, Young Youn Cho, Eun Ju Cho, Su Jong Yu, (unknown), Yoon Jun Kim, Soon Koo Baik, Jung‐Hwan Yoon	61
16	Integrative analysis of genomic and epigenomic regulation of the transcriptome in liver cancer 2017 ·Nature Communications ·Hyun Goo Woo, Ji Hye Choi, Sarah Yoon, Byul A Jee, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Jung‐Hwan Yoon, Nam‐Joon Yi, Kwang‐Woong Lee, Kyung‐Suk Suh, Yoon Jun Kim	88
17	Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases 2016 ·Clinical and Molecular Hepatology ·Hyeki Cho, Yuri Cho, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Kook‐Hwan Oh, Kyoung Bun Lee, (unknown), Jung‐Hwan Yoon, Yoon Jun Kim	11
18	A Phase II Study of the Efficacy and Safety of the Combination Therapy of the MEK Inhibitor Refametinib (BAY 86-9766) Plus Sorafenib for Asian Patients with Unresectable Hepatocellular Carcinoma 2014 ·Clinical Cancer Research ·Ho Yeong Lim, Jeong Heo, Hye Jin Choi, Cheng-Yao Lin, Jung‐Hwan Yoon, Chiun Hsu, Kun‐Ming Rau, Ronnie T. P. Poon, Winnie Yeo, Joong‐Won Park, Miah Hiang Tay, Wen-Son Hsieh, Christian Kappeler, Prabhu Rajagopalan, Heiko Krissel, Michael Jeffers, Chia‐Jui Yen, Won Young Tak	86
19	Identification of a Cholangiocarcinoma-Like Gene Expression Trait in Hepatocellular Carcinoma 2010 ·Cancer Research ·Hyun Goo Woo, Jeong‐Hoon Lee, Jung‐Hwan Yoon, Chung Yong Kim, Hyo‐Suk Lee, Ja June Jang, Nam‐Joon Yi, Kyung‐Suk Suh, Kuhn Uk Lee, Eun Sung Park, Snorri S. Thorgeirsson, Yoon Jun Kim	149
20	Gene Expression–Based Recurrence Prediction of Hepatitis B Virus–Related Human Hepatocellular Carcinoma 2008 ·Clinical Cancer Research ·Hyun Goo Woo, Eun Sung Park, Jae Hee Cheon, Ju Han Kim, Ju‐Seog Lee, Byung‐Joo Park, Won Kim, Su Cheol Park, Young Jin Chung, Byeong Gwan Kim, Jung‐Hwan Yoon, Hyo-Suk Lee, Chung Yong Kim, Nam‐Joon Yi, Kyung‐Suk Suh, Kuhn Uk Lee, In‐Sun Chu, Tania Roskams, Snorri S. Thorgeirsson, Yoon Jun Kim	123

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact